Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Myocardial Injury Often Miscoded as Type 2 MI

News Conference News ACC 2019

Myocardial Injury Often Miscoded as Type 2 MI

April 02, 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

News Conference News ACC 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

March 27, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

News Conference News ACC 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

March 19, 2019

The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial

Presentation ACC 2019

The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial

Presenter: Michel R Le May

March 19, 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Presentation ACC 2019

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Presenter: Renato Lopes

March 18, 2019

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

News Conference News ACC 2019

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

March 18, 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

March 17, 2019

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Presentation ACC 2019

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Presenter: Adam D. DeVore

March 17, 2019

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

News Conference News ACC 2019

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

March 16, 2019

Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks

News Conference News ACC 2019

Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks

March 07, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.